BROWN UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1764-01-01

Employees: 1K

Market Cap: -

Website: http://www.brown.edu

Clinical Trials

BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

Phase 1

Completed

Conditions: Metastatic Pancreatic Cancer

Interventions: Drug: Dose level 2/MTD
Drug: Dose level 3
Drug: Dose level 1

First Posted Date: 2012-12-06

Last Posted Date: 2020-02-17

Lead Sponsor: Brown University

Target Recruit Count: 35

Registration Number: NCT01744353

Locations: 🇺🇸
The Miriam Hospital, Providence, Rhode Island, United States
🇺🇸
Rhode Island Hospital (including Newport and East Greenwich locations), Providence, Rhode Island, United States
🇺🇸
Memorial Hospital, Pawtucket, Rhode Island, United States

Intensive Outpatient Services for Teens

Phase 1

Completed

Conditions: Depression
Suicide

Interventions: Behavioral: Standard Care
Behavioral: Intensive Outpatient CBT

First Posted Date: 2012-11-26

Last Posted Date: 2018-01-23

Lead Sponsor: Brown University

Target Recruit Count: 140

Registration Number: NCT01732601

Locations: 🇺🇸
Brown University, Providence, Rhode Island, United States

Effectiveness of Interpersonal Psychotherapy (IPT) for Men and Women Prisoners With Major Depression

Phase 3

Completed

Conditions: Major Depressive Disorder

Interventions: Behavioral: Group IPT for Depression + TAU

First Posted Date: 2012-09-14

Last Posted Date: 2016-01-13

Lead Sponsor: Brown University

Target Recruit Count: 181

Registration Number: NCT01685294

Locations: 🇺🇸
Massachusetts Correctional Institute - Old Colony Correctional Center, Bridgewater, Massachusetts, United States
🇺🇸
Massachusetts Correctional Institution - Framingham, Framingham, Massachusetts, United States
🇺🇸
Massachusetts Correctional Institution - Norfolk, Norfolk, Massachusetts, United States

and more 2 locations

Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma

Phase 2

Terminated

Conditions: Burkitts Lymphoma
T Cell Lymphomas
Diffuse Large Cell Lymphoma
Acute Myeloid Leukemia/Acute Lymphoblastic Leukemia
Mantle Cell Lymphoma

Interventions: Biological: cellular immunotherapy

First Posted Date: 2012-09-14

Last Posted Date: 2022-03-04

Lead Sponsor: Brown University

Target Recruit Count: 6

Registration Number: NCT01685606

Locations: 🇺🇸
The Miriam Hospital, Providence, Rhode Island, United States
🇺🇸
Rhode Island Hospital, Providence, Rhode Island, United States

A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer

Phase 1

Terminated

Conditions: Anal Cancer

Interventions: Biological: Treatment
Drug: 5FU
Drug: Mitomycin
Radiation: IMRT

First Posted Date: 2012-08-23

Last Posted Date: 2020-02-17

Lead Sponsor: Brown University

Target Recruit Count: 11

Registration Number: NCT01671488

Locations: 🇺🇸
The Miriam Hospital, Providence, Rhode Island, United States
🇺🇸
Montefiore Medical Center, New York, New York, United States
🇺🇸
Rhode Island Hospital, Providence, Rhode Island, United States

Adjuvant Aflibercept for Metastatic Colorectal Cancer

Phase 2

Terminated

Conditions: Metastatic Colorectal Cancer

Interventions: Drug: Aflibercept

First Posted Date: 2012-08-21

Last Posted Date: 2020-02-17

Lead Sponsor: Brown University

Target Recruit Count: 10

Registration Number: NCT01669720

Locations: 🇺🇸
Rhode Island Hospital (East Greenwich and Newport), Providence, Rhode Island, United States
🇺🇸
The Miriam Hospital, Providence, Rhode Island, United States

Community-Based Integrated Treatment for Adolescents

Phase 1

Completed

Conditions: Depression
Alcohol Use

Interventions: Behavioral: Integrated Cognitive Behavioral Therapy
Behavioral: Standard Care

First Posted Date: 2012-08-17

Last Posted Date: 2018-01-23

Lead Sponsor: Brown University

Target Recruit Count: 114

Registration Number: NCT01667159

Locations: 🇺🇸
Brown University, Providence, Rhode Island, United States

Cabazitaxel and Radiation For Patients With Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Cabazitaxel

First Posted Date: 2012-07-26

Last Posted Date: 2022-03-04

Lead Sponsor: Brown University

Target Recruit Count: 5

Registration Number: NCT01650285

Locations: 🇺🇸
Miriam Hospital, Providence, Rhode Island, United States

Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer

Phase 2

Terminated

Conditions: Melanoma
Prostate Cancer
Renal Cancer

Interventions: Drug: Naltrexone

First Posted Date: 2012-07-26

Last Posted Date: 2022-03-04

Lead Sponsor: Brown University

Target Recruit Count: 7

Registration Number: NCT01650350

Locations: 🇺🇸
Miriam Hospital, Providence, Rhode Island, United States

Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms

Phase 1

Completed

Conditions: Alcohol Drinking

Interventions: Drug: Topiramate
Drug: Placebo

First Posted Date: 2012-07-16

Last Posted Date: 2020-10-20

Lead Sponsor: Brown University

Target Recruit Count: 82

Registration Number: NCT01641445

Locations: 🇺🇸
Brown University, Center for Alcohol and Addiction Studies, Providence, Rhode Island, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy